Age: 25
Free Agency: 2027 (UFA)
Accrued Seasons: 2
- Height: 6'4"
- Weight: 229
- College: Kentucky
- Entry: 2023 Draft, Round 2, #33 overall (Titans)
- 2024 Salary Cap Charge: $2,168,673 (0.83% of cap)
- 2024 Cash Payout: $1,183,735 (0.51% of spending)
- 2024 Cash to Cap Ratio: 0.55
- Contract Value: $9,542,162 ($2,385,541 APY)
- Fully Guaranteed Money: $8,730,957
- Contract Ranking: 53/109 at QB
Current Contract
(Drafted, signed 2023)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Signing Bonus | Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 24 | $750,000 | $984,938 | $0 | $750,000 | $1,734,938 | 0.8% | |||||
| 2024 | 25 | $915,000 | $984,938 | $268,735 | $1,183,735 | $2,168,673 | 0.8% | |||||
| 2025 | 26 | $1,030,000 | $984,938 | $587,470 | $1,617,470 | $2,602,408 | 0.9% | |||||
| 2026 | 27 | $1,145,000 | $984,938 | $906,205 | $1,240,000 | $3,036,143 | 1.0% | |||||
| Total | $3,840,000 | $3,939,752 | $1,762,410 | $4,791,205 | $9,542,162 | |||||||
Contract Notes
Will Levis signed a four year contract worth $9,542,162 with the Titans on July 22, 2023. The contract has $8,730,957 in guarantees. He received a signing bonus worth $3,939,752.
Cash Flows
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash Due | $4,689,752 | $1,183,735 | $1,617,470 | $2,051,205 |
| Running Cash | $4,689,752 | $5,873,487 | $7,490,957 | $9,542,162 |
Career Earnings: $5,873,487
Career APY: $2,936,744
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Titans | Drafted | Active | 2023 | 4 | $9,542,162 | $2,385,541 | $8,730,957 | $5,873,487 | 61.6% | $2,936,744 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Titans | 2 | $5,873,487 | $2,936,744 | $3,903,611 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | Titans | $750,000 | $984,938 | $0 | $750,000 | $1,734,938 | 0.8% | $4,689,752 | ||
| 2024 | Titans | $915,000 | $984,938 | $268,735 | $1,183,735 | $2,168,673 | 0.8% | $1,183,735 | ||
| 2025 | Titans | $1,030,000 | $984,938 | $587,470 | $1,617,470 | $2,602,408 | 0.9% | $1,617,470 | ||
| 2026 | Titans | $1,145,000 | $984,938 | $906,205 | $1,240,000 | $3,036,143 | 1.0% | $2,051,205 | ||
| Total | $3,840,000 | $3,939,752 | $1,762,410 | $4,791,205 | $9,542,162 | $9,542,162 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | Passing | Rushing | Fumbles | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | Comp/Att | Pct | Yards | TD | INT | Sacked | Rating | Att | Yards | Avg | TD | Total | Lost | ||
| 2023 | 9 | 2 | 6 | 50.3% | 0.0% | 149/255 | 58.4% | 1808 | 8 | 4 | 28 | 84.2 | 25 | 57 | 2.3 | 1 | 0 | 0 |
| 2024 | 12 | 0 | 3 | 56.8% | 0.0% | 190/301 | 63.1% | 2091 | 13 | 12 | 41 | 81.4 | 45 | 183 | 4.1 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $9,091,000 | $2,385,541 |
| Injury Adjusted | $9,091,000 | $2,385,541 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.